WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles：
Related suggestion：
Handy with fashion techChina remains biggest export country for German electrical, digital industry in 2021New solar project in operationChina's Huawei to launch HarmonyOS for smartphonesChina's nonChina deploys inXi Meets UNESCO ChiefChina gathers pace in integrating new technologies into transportation sectorWhy foreign enterprises double down on investment in ChinaChina launches new remote
0.2277s , 6495.078125 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Global Glossary news portal